Your browser doesn't support javascript.
loading
Metabolite profiles and mass balance of fuzuloparib, a novel poly (ADP-ribose) polymerase inhibitor, in subjects with advanced solid cancers.
Bian, Yicong; Meng, Jian; Ma, Sheng; Li, Guangze; Wang, Yuya; Li, Shaorong; Liu, Linsheng; Huang, Chenrong; Zhang, Hua; Zhong, Dafang; Miao, Liyan.
Afiliação
  • Bian Y; Department of Pharmacy, the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Meng J; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Ma S; Department of Pharmacy, the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Li G; Jiangsu Hengrui Medicine Co., Ltd, Lianyungang, China.
  • Wang Y; Jiangsu Hengrui Medicine Co., Ltd, Lianyungang, China.
  • Li S; Jiangsu Hengrui Medicine Co., Ltd, Lianyungang, China.
  • Liu L; Department of Pharmacy, the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Huang C; Department of Pharmacy, the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Zhang H; Department of Pharmacy, the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Zhong D; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Miao L; Department of Pharmacy, the First Affiliated Hospital of Soochow University, Suzhou, China.
Br J Clin Pharmacol ; 88(7): 3307-3320, 2022 07.
Article em En | MEDLINE | ID: mdl-35112382

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Prevencao_e_fatores_de_risco / Agentes_cancerigenos / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Prevencao_e_fatores_de_risco / Agentes_cancerigenos / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China